The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial is a research paper published in Brain (2023). On theSindex it has a DataRank of 0. It has been cited 147 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Brain Research UK
Grant: 201819-18
Medical Research Council
Grant: MR/K015184/1
National Health
University of Birmingham
department of Health and Social Care
Ministry of Defence
Brain fellowship
Brain research UK
National Institute for Health Research (NIHR)
a Sir Jules Thorn Award for Biomedical Science
Intramural Research
National Institute
Association of British
Enterprising Birmingham
Medical Research Council
FWCI
23.55
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
Additional file 1 of Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension